The Genetic Control of Human Ia Alloantigens: A Three‐Loci Model Derived from the Immunochemical Analysis of ‘Supertypic’ Specificities
- 1 September 1982
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 66 (1), 5-36
- https://doi.org/10.1111/j.1600-065x.1982.tb00432.x
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Cross-Reactivity between the First and Second Segregant Series of the HLA SystemTissue Antigens, 2008
- Further characterization of two “DR supertypic” specificities additional evidence that they reside on molecules different from those carrying HLA-DR locus specificitiesHuman Immunology, 1981
- Human Ia molecules carrying DC1 determinants differ in both α- and β-subunits from Ia molecules carrying DR determinantsNature, 1981
- Immunochemical Definition of the New Dr Specificity 8WDRw13Immunological Communications, 1981
- HLA-DR TYPING BY RADIOIMMUNOASSAYTransplantation, 1980
- Evidence for two homologous, but nonidentical, Ia molecules determined by the I-EC subregion.The Journal of Experimental Medicine, 1979
- Structural polymorphism of human DR antigensNature, 1979
- Heavy HLA-DR (Ia) antigen chain is controlled by the MHC regionNature, 1978
- Cross-reactivity between H-2K and H-2D products. I. Evidence for extensive and reciprocal serological cross-reactivityThe Journal of Experimental Medicine, 1975
- The papain susceptibility of IgG myeloma proteins of different heavy chain subclassesImmunochemistry, 1970